Proudfoot, Clare
Gautam, Raju
Cristino, Joaquim
Agrawal, Rumjhum
Thakur, Lalit
Tolley, Keith
Funding for this research was provided by:
Novartis Pharma AG
Article History
Received: 13 September 2021
Accepted: 25 May 2022
First Online: 5 July 2022
Declarations
:
: C. Proudfoot, R. Gautam, J. Cristino, R. Agrawal and L. Thakur are employees of Novartis. C. Proudfoot and J. Cristino hold stocks in Novartis. K. Tolley is an employee of Tolley Health Economic Ltd., UK and provided consultancy to Novartis Pharma AG, Basel, Switzerland.
: Since the study did not involve the participation of humans, the ethical approval was not applicable.
: Not applicable.
: Consent for publication was obtained from all the authors and have reviewed the article.